Kimia Biosciences Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Kimia Biosciences Ltd is ₹ 33.82 as of 12 Jun 15:30 . The P/E Ratio of Kimia Biosciences Ltd changed from 35.1 on March 2021 to 20.9 on March 2025 . This represents a CAGR of -9.85% over 5 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Kimia Biosciences Ltd changed from ₹ 179.55 crore on March 2021 to ₹ 201.13 crore on March 2025 . This represents a CAGR of 2.30% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 years The revenue of Kimia Biosciences Ltd for the Mar '26 is ₹ 28.21 crore as compare to the Dec '25 revenue of ₹ 30.2 crore. This represent the decline of -6.59% The revenue of Parmax Pharma Ltd for the Mar '26 is ₹ 3.34 crore as compare to the Dec '25 revenue of ₹ 4.33 crore. This represent the decline of -22.86% The ebitda of Kimia Biosciences Ltd for the Mar '26 is ₹ 3.67 crore as compare to the Dec '25 ebitda of ₹ 6.65 crore. This represent the decline of -44.81% The ebitda of Parmax Pharma Ltd for the Mar '26 is ₹ -1.52 crore as compare to the Dec '25 ebitda of ₹ -0.19 crore. This represent the growth of 700% The net profit of Kimia Biosciences Ltd changed from ₹ 1.44 crore to ₹ 0.37 crore over 8 quarters. This represents a CAGR of -49.31% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.58 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kimia Biosciences Ltd

Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993.
The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019.
Since then, it engages in the business of Pharmaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
It came out with a public issue in Feb.'95 to part-finance the project.

About Parmax Pharma Ltd

Incorporated in November, 1994, Parmax Pharma Limited (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Company has manufacturing facilities approved by Indian regulatory bodies such as CDSCO, State FDA, and operates under GMP-compliant systems. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Kimia Biosciences Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Kimia Biosciences Ltd or Parmax Pharma Ltd?

Market cap of Kimia Biosciences Ltd is 160 Cr while Market cap of Parmax Pharma Ltd is 22 Cr

What are the key factors driving the stock performance of Kimia Biosciences Ltd and Parmax Pharma Ltd?

The stock performance of Kimia Biosciences Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kimia Biosciences Ltd and Parmax Pharma Ltd?

As of June 15, 2026, the Kimia Biosciences Ltd stock price is INR ₹33.82. On the other hand, Parmax Pharma Ltd stock price is INR ₹59.32.

How do dividend payouts of Kimia Biosciences Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Kimia Biosciences Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.